Latest News

No More Dreaded 500 Metre ‘Walk of Shame’ For Kiwis With MS?

November 27, 2020 | Advocacy, Life with MS, Treatments

Media Release No More Dreaded 500 Metre ‘Walk of Shame’ For Kiwis With MS? A six year battle to allow multiple sclerosis patients continued access to vital funded drug treatments may soon be over, with news that Pharmac is finally […]


Announcement: PHARMAC consultation: proposal to widen access and transition the process for funded access to multiple sclerosis treatments

November 27, 2020 | Advocacy, Life with MS, Treatments

Pharmac have released public consultation on a proposal to widen access to funded multiple sclerosis treatments and transition access from the Multiple Sclerosis Treatment Assessment Committee (MSTAC) Panel to a standard Special Authority. Please follow this link to read the […]


[Updated] COVID-19 – Advice for Patients

April 9, 2020 | Advocacy, Life with MS, Research, Support, Treatments

NOTE: This post was updated on the 9/04/2020, to reflect the requirements of Alert Level 4 and emerging data. Key updates: Updated information based on very early emerging data Updated information about your upcoming appointments Latest travel advice Information for […]


Actively Advocating: Widening the Access to MS Treatments

April 7, 2020 | Advocacy, Treatments

In February Pharmac published the minutes of the Pharmacology and Therapeutics Advisory Committee’s (PTAC) November 2019 meeting. The minutes reported the outcome of the meeting at which MSNZs submission to widen the Special Authority (SA) access criteria for disease modifying […]


Ocrelizumab approved for funding

October 7, 2019 | Advocacy, Life with MS, Treatments

Media Release – 7 October 2019 Hundreds with Multiple Sclerosis ‘Abandoned’ due to Pharmac Drug Access Criteria There’s concern that a Pharmac decision to fund the drug Ocrelizumab (Ocrevus) for certain patients with multiple sclerosis from December 1st will still […]